Hemorrhage Control System Global Market Report 2025

The hemorrhage control systems market size has grown strongly in recent years. It will grow from $3.26 billion in 2024 to $3.48 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the increasing incidence of traumatic battlefield injuries, rising demand for emergency care, expanding military applications, a growing elderly population, and greater awareness of hemorrhage control techniques.

The hemorrhage control systems market size is expected to see strong growth in the next few years. It will grow to $4.45 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the increasing prevalence of trauma cases, a rising number of surgical procedures, the growing adoption of minimally invasive techniques, higher healthcare expenditure, and a surge in severe war-related injuries. Key trends expected during this period include the development of advanced hemostatic agents, the emergence of portable and user-friendly hemorrhage control devices, the integration of smart technology, innovations in bioactive dressings, and advancements in personalized and precision medicine approaches.

The increasing number of trauma cases is expected to drive the growth of the hemorrhage control systems market in the coming years. Trauma cases refer to medical emergencies resulting from physical injuries caused by external forces such as road traffic accidents, workplace incidents, sports injuries, and natural disasters. The rising frequency of such incidents underscores the need for effective hemorrhage control solutions that can manage severe bleeding, improve patient survival rates, and minimize complications in emergency medical care. For instance, in September 2024, the UK Department for Transport reported that police forces recorded 73,920 casualties in 2022, up from 66,236 cases in 2021. This increasing prevalence of trauma cases is contributing to the growing demand for hemorrhage control systems.

Companies operating in the hemorrhage control systems market are emphasizing the development of advanced medical products, particularly in maternal healthcare, to enhance bleeding management in critical situations. A notable innovation in this field includes postpartum hemorrhage (PPH) control devices, which are designed to prevent excessive bleeding after childbirth by promoting clot formation or constricting blood vessels. For example, in September 2024, Organon Canada, a healthcare company, launched the JADA System, a medical device that manages postpartum hemorrhage using low-level vacuum technology. This technology facilitates natural uterine contraction, providing a non-invasive and effective treatment for postpartum bleeding when conservative management is necessary. Such advancements are addressing significant gaps in maternal healthcare and improving patient outcomes.

In May 2022, Ethicon, a US-based healthcare product manufacturer, acquired GATT Technologies B.V. to expand its portfolio of hemostatic and sealing solutions. This acquisition enabled Ethicon to incorporate GATT Technologies’ advanced synthetic hemostats and sealants, enhancing its capability to effectively manage surgical bleeding. GATT Technologies B.V., a Netherlands-based company specializing in hemorrhage control systems, contributed innovative solutions to Ethicon’s product offerings, further strengthening its position in the market.

Major players in the hemorrhage control system market are Medtronic plc, Stryker Corporation, Becton, Dickinson and Company (BD), Baxter International Inc., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Ethicon, CryoLife Inc., B. Braun Melsungen AG, Z-Medica LLC, Medicom, Axio Biosolutions, Aero Healthcare Pty Ltd., Penn Care Inc., Tricol Biomedical Inc., Hemostasis LLC, RevMedx Inc., Turtle Engineering Ltd., OMNI-STAT Medical Inc., Unicare Biomedical Inc.

North America was the largest region in the hemorrhage control system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hemorrhage control systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hemorrhage control systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A hemorrhage control system is a medical device designed to manage severe bleeding in trauma situations, preventing life-threatening blood loss. These systems play a crucial role in stabilizing patients by controlling hemorrhage and preventing hypovolemic shock, ensuring critical care can be administered during transport to medical facilities. They are essential in emergency settings, providing immediate stabilization before further treatment.

The primary product types in the hemorrhage control systems market include dressings, hemostatic agents, clamps, tourniquets, surgical sealants, and blood products. Hemostatic dressings are specialized wound coverings that rapidly control bleeding by promoting clotting and blood vessel constriction. These systems are used in various surgical applications, including cardiovascular, general, plastic, orthopedic, and neurosurgery. They are distributed through multiple channels, such as direct sales, distributors, online retail, and pharmacies, and are utilized by hospitals, ambulatory surgery centers (ASCs), specialty clinics, and other healthcare providers.

The hemorrhage control system market research report is one of a series of new reports that provides hemorrhage control system market statistics, including the hemorrhage control system industry global market size, regional shares, competitors with the hemorrhage control system market share, detailed hemorrhage control system market segments, market trends, and opportunities, and any further data you may need to thrive in the hemorrhage control system industry. This hemorrhage control system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hemorrhage control systems market consists of sales of hemorrhage control kits, wound packing devices, and pressure dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.